Aurinia Pharmaceuticals Inc (AUPH) Social Stream
AURINIA PHARMACEUTICALS INC (AUPH) Price Targets From Analysts
Use the tables below to see what analysts covering AURINIA PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 8 | $40 | $26 | $34.125 | $7.92 | 330.87% |
| 2021-12-10 | 8 | $40 | $26 | $33.875 | $7.92 | 327.71% |
| 2022-01-09 | 8 | $40 | $26 | $33.625 | $7.92 | 324.56% |
| 2022-02-10 | 7 | $40 | $26 | $33.625 | $7.92 | 324.56% |
| 2022-03-01 | 8 | $34 | $23 | $31.125 | $7.92 | 292.99% |
| 2022-03-09 | 8 | $34 | $18 | $27.437 | $7.92 | 246.43% |
| 2022-04-25 | 7 | $34 | $18 | $26.5 | $7.92 | 234.6% |
| 2022-04-28 | 8 | $34 | $18 | $25.937 | $7.92 | 227.49% |
| 2022-05-11 | 8 | $30 | $15 | $23.812 | $7.92 | 200.66% |
| 2022-07-27 | 8 | $30 | $15 | $23.312 | $7.92 | 194.34% |
| 2022-08-05 | 8 | $30 | $15 | $23.187 | $7.92 | 192.77% |
| 2022-08-08 | 8 | $30 | $13 | $22.437 | $7.92 | 183.3% |
| 2022-08-09 | 8 | $30 | $13 | $21.312 | $7.92 | 169.09% |
| 2022-11-04 | 8 | $30 | $10 | $19.062 | $7.92 | 140.68% |
| 2022-11-07 | 8 | $15 | $5.5 | $11.875 | $7.92 | 49.94% |
| 2023-01-04 | 8 | $15 | $5.5 | $12.187 | $7.92 | 53.88% |
| 2023-02-23 | 8 | $15 | $5.5 | $12.562 | $7.92 | 58.61% |
| 2023-03-01 | 8 | $15 | $5.5 | $12.5 | $7.92 | 57.83% |
| 2023-03-02 | 7 | $15 | $9 | $13 | $7.92 | 64.14% |
| 2023-04-05 | 8 | $15 | $9 | $13 | $7.92 | 64.14% |
| 2023-04-27 | 8 | $15.001 | $9 | $13 | $7.92 | 64.14% |
| 2023-05-04 | 8 | $15.001 | $9 | $13.285 | $7.92 | 67.74% |
| 2023-08-04 | 8 | $15 | $12 | $13.714 | $7.92 | 73.16% |
| 2023-10-11 | 8 | $15 | $12 | $14 | $7.92 | 76.77% |
| 2023-11-03 | 8 | $15 | $9.5 | $13.214 | $7.92 | 66.84% |
The Trend in the Analyst Price Target
AUPH's average price target has moved down $19.62 over the prior 21 months.
AUPH reports an average of 39.58% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-01 | 8 | 15.000 | 5.5 | 12.500 | 8.99 | 39.04% |
| 2023-03-02 | 8 | 15.000 | 9.0 | 13.000 | 8.94 | 45.41% |
| 2023-04-05 | 8 | 15.000 | 9.0 | 13.000 | 9.98 | 30.26% |
| 2023-04-24 | 8 | 15.001 | 9.0 | 13.000 | 10.75 | 20.93% |
| 2023-11-03 | 8 | 15.000 | 9.5 | 13.214 | 8.23 | 60.56% |
AUPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.63 | 5 | 1 | 2 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
AUPH's average broker recommendation rating worsened by 0.48 over the prior 22 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- AURINIA PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 2452.14% of all US stocks.
- AURINIA PHARMACEUTICALS INC's average analyst price target is greater than 765.47% of all US stocks.
- In the context of all US stocks, AURINIA PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1777.15% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, AURINIA PHARMACEUTICALS INC's number of analysts covering the stock is higher than 1625.58% of them.
In the Pharmaceutical Products industry, HCM, ORGO, and ANAB are the three stocks most similar to AURINIA PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is AUPH a Buy, Hold or Sell? See the POWR Ratings now!